article thumbnail

Things To Avoid With Degenerative Disc Disease

Oviedo Chiropractic

Here are some things to avoid with degenerative disc disease. However, for those living with degenerative disc disease, this process generally happens earlier—and causes more pain. If you’ve recently been diagnosed with disc degeneration, you’re probably wondering what to expect.

article thumbnail

ReGelTec Announces First Patient Treated in U.S. IDE Clinical Trial for HYDRAFIL System to Treat Chronic Low Back Pain

OrthoSpineNews

a company developing a percutaneous hydrogel implant for the treatment of chronic low back pain caused by degenerative disc disease, announced it has treated the first patient in its HYDRAFIL-D FDA investigational device exemption (IDE) clinical trial for its HYDRAFIL ® System for disc augmentation. Jasper, Ga.;

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Degenerative Disc Disease Treatment Market Is Expected To Reach Revenue Of USD 66.2 Bn By 2033, At 7.7% CAGR: Dimension Market Research

OrthoSpineNews

Advancements and Projections in the Global Degenerative Disc Disease Treatment Market: Insights, Trends, Opportunities, and Recent Developments New York, Oct. 08, 2024 (GLOBE NEWSWIRE) — Overview – The Global Degenerative Disc Disease Treatment Market is projected to reach USD 34.0

article thumbnail

Spine BioPharma, Inc. Announces Completion of Enrollment for Phase 3 Clinical Trial of SB-01 to Address Chronic Low Back Pain

OrthoSpineNews

a development stage company committed to non-opiate, non-surgical therapies for Degenerative Disc Disease (DDD), today announced the completion of enrollment of its U.S. The Phase 3 MODEL trial (MOderate – Severe Degenerative Disc Disease Evaluation of the Lumbar Spine) … The post Spine BioPharma, Inc.

article thumbnail

DiscGenics Announces US FDA Approval to Proceed with Phase III Clinical Evaluation of Allogeneic, Injectable Disc Progenitor Cell Therapy for Symptomatic Lumbar Degenerative Disc Disease

OrthoSpineNews

Receives FDA acceptance on Phase III clinical protocols for parallel pivotal and confirmatory trials Achieves alignment with FDA on Chemistry, Manufacturing, and Controls (CMC) aspects of Phase III program SALT LAKE CITY, July 16, 2024 /PRNewswire/ — DiscGenics, Inc.,

article thumbnail

Groundbreaking Spine Surgery Performed by Dr. Ehsan Jazini Marks New Era in Motion-Preserving Procedures

OrthoSpineNews

” This trailblazing surgery signals a shift in how spine disorders, particularly those involving nerve pain, disc herniation, degenerative disc disease, and spinal stenosis, can be addressed.

article thumbnail

Spinal Stabilization Technologies™ Announces Enrollment of First U.S. Patient in IDE Trial for PerQdisc™ Nucleus Replacement Device

OrthoSpineNews

based trial to evaluate its PerQdisc system for patients suffering from degenerative disc disease (DDD). patient in its Investigational Device Exemption (IDE) clinical trial for the PerQdisc Nucleus Replacement Device (NRD). This event marks the beginning of SST’s U.S.-based